Maria Wigren

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Tolerogenic dendritic cells generated in vitro using a novel protocol mimicking mucosal tolerance mechanisms represent a potential therapeutic cell platform for induction of immune tolerance.

Tolerogenic dendritic cells generated in vitro using a novel protocol mimicking mucosal tolerance mechanisms represent a potential therapeutic cell platform for induction of immune tolerance.

Journal: Frontiers in immunology

Published: September 15, 2022

Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus.

Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus.

Journal: Vascular pharmacology

Published: August 19, 2020

Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice.

Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice.

Journal: Circulation

Published: May 29, 2019

Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease.

Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease.

Journal: Diabetes & vascular disease research

Published: December 22, 2018

B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.

B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.

Journal: Vascular pharmacology

Published: June 20, 2018

Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis.

Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis.

Journal: Atherosclerosis

Published: November 05, 2017

Plasma stem cell factor levels are associated with risk of cardiovascular disease and death.

Plasma stem cell factor levels are associated with risk of cardiovascular disease and death.

Journal: Journal of internal medicine

Published: August 27, 2017

Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease.

Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease.

Journal: EBioMedicine

Published: July 25, 2017

IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis.

IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis.

Journal: Cardiovascular research

Published: December 07, 2016

Recent advances on CD4+ T cells in atherosclerosis and its implications for therapy.

Recent advances on CD4+ T cells in atherosclerosis and its implications for therapy.

Journal: European journal of pharmacology

Published: November 29, 2016

FADD, Caspase-3, and Caspase-8 and Incidence of Coronary Events.

FADD, Caspase-3, and Caspase-8 and Incidence of Coronary Events.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: October 22, 2016

Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes.

Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes.

Journal: BMC cardiovascular disorders

Published: April 14, 2016

Showing 1-12 of 28

Last Updated: 09/26/2026